🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts privately for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the service has taken down violative material and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, populated with photos of weight loss, positive testimonials and step-by-step guides for preparing or administering at home.

After minutes of joining one group, a vendor posted contact information, where most transactions take place. The vendor sent an guidebook and promised delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Within these groups, posts display black plastic parcels with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service stated it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly significant medical dangers”.